Follow Us:
Tivozanib Exporter From India

Tivozanib

Tivozanib is an anticancer drug belonging to the tyrosine kinase inhibitor (TKI) group of medicines. It is mainly used for the treatment of advanced renal cell carcinoma (kidney cancer), particularly in adults who have received previous systemic therapy. It works by selectively inhibiting vascular endothelial growth factor (VEGF) receptors 1, 2 and 3, thereby blocking the formation of new blood vessels that supply nutrients and oxygen to cancer cells. This helps slow tumour growth and progression. Tivozanib is available in capsule form for oral administration. Common side effects include hypertension, diarrhoea, fatigue, loss of appetite and hoarseness. Serious adverse effects may include liver problems, heart complications and bleeding. It should be used only under specialist medical supervision.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Tivozanib

Tivozanib was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Tivozanib

Availability of Tivozanib

Delivery of Tivozanib

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Tivozanib.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Tivozanib.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Tivozanib, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Tivozanib Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Tivozanib

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Tivozanib Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Tivozanib, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Tivozanib

The export of Tivozanib from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Tivozanib Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Tivozanib specifications, certificates of analysis, and other supporting documents required for Tivozanib export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Tivozanib export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Tivozanib regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Tivozanib documentation, labelling, Tivozanib manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Tivozanib Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Tivozanib, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.